Clinical Research

Enlivex Therapeutics Ltd.

Address
14, Einstein Street

Sponsor Overview

assignment
2
sponsored trials
science
1
molecule
location_city
11
research centres
public
2
countries
person_search
11
investigators

Specializations

Musculoskeletal Disorders

Enlivex Therapeutics Ltd. is focused on clinical research in knee osteoarthritis, with attention to the management of joint pain, stiffness, and functional limitation associated with degenerative musculoskeletal disease.

  • Osteoarthritis of the knee
  • Joint function and mobility
  • Pain-related disability

The sponsor’s research activity is centered on therapeutic approaches intended for the affected knee joint in patients with primary osteoarthritis.

Intra-articular Therapy

The company’s clinical portfolio includes work in intra-articular administration, reflecting interest in locally delivered treatment strategies for knee joint disease.

  • Local joint injection
  • Synovial and articular treatment
  • Targeted knee intervention

This area of interest emphasizes therapies designed to act directly within the joint environment rather than through systemic treatment.

Pain and Functional Outcomes

Research activity is directed toward clinical measures of pain relief and improved physical function in people living with knee osteoarthritis.

  • WOMAC pain
  • WOMAC function
  • Symptom burden

The sponsor’s therapeutic interest includes outcomes relevant to everyday mobility, joint comfort, and functional recovery in chronic degenerative joint disease.

Regenerative and Immunomodulatory Approaches

Enlivex Therapeutics Ltd. is engaged in research around Allocetra, a treatment concept being evaluated for its potential role in modifying the local joint environment in osteoarthritis.

  • Cell-based therapy
  • Immune modulation
  • Joint tissue preservation

Its clinical interest lies in therapeutic strategies for knee osteoarthritis that address both symptom control and disease-related joint impairment.

Sponsored Trials

Trial Name Country Status
Phase IIb Randomized Double‑Blind Placebo‑Controlled Study of Intra‑Articular Allocetra‑OTS in Adults with Primary Knee OsteoarthritisDenmark DenmarkPoland PolandRecruiting
Randomized, Double-Blind, Placebo-Controlled Study of Intra-Articular Allocetra-OTS in Patients with Knee OsteoarthritisDenmark DenmarkNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 1 total (100% not shared with other sponsors)

This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
9%
Return partnership rate
1 of 11 sites collaborated multiple times

This sponsor has worked with 11 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Musculoskeletal Diseases2 trials
    238 other sponsors

Partnered Research Centres

11 centres
location_city
assignment30
Centrum Leczenia MIGRE
Address
ul. Lubinowa 12/7, 52-210 Wroclaw
Learn morearrow_forward
location_city
assignment1
Centrum Medyczne Hetmanska
Address
ul.Hetmanska 55/1, 60-218 Poznan
Learn morearrow_forward
location_city
assignment12
Centrum Medyczne Justmed Sp. z o.o.
Address
Ul. Marymoncka 14/ U1 U2, 01-696 Warsaw
Learn morearrow_forward
location_city
assignment112
Centrum Medyczne Plejady Magdalena Celinska Loewenhoff Michal Zolnowski sp.k.
Address
Ul. Tadeusza Szafrana 5d / U2-U5, 30-363 Krakow
Learn morearrow_forward
location_city
assignment24
Dc-Med Michal Kowalski sp.k.
Address
Ul. Dworcowa 5, 58-100 Swidnica
Learn morearrow_forward
location_city
assignment36
ETG Lublin
Address
Ul. Wladyslawa Kunickiego 26a, 20-412 Lublin
Learn morearrow_forward
Page 1 of 2

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Enlivex Therapeutics Ltd..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.